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Abstract
Objective: (1) To investigate the incidence of laryngeal involvement in a large series of patients with pemphigus
vulgaris, using endoscopic examination, (2) to describe the lesions, and (3) to establish a classification of
laryngeal involvement in pemphigus vulgaris based on the location of the lesions.
Study design: Prospective study.
Methods: A total of 40 sequentially treated pemphigus vulgaris patients, diagnosed using clinical, histological
and immunofluorescence criteria, were evaluated for laryngeal manifestations using endoscopic examination.
The results were used to establish a graded classification of laryngeal involvement according to the location of
the lesions.
Results: Active laryngeal lesions (ulcers or blisters) were found in 16 patients (40 per cent). Of these, 37.5 per
cent were classified as grade I, 20 per cent as grade II, 20 per cent as grade III and 17.5 per cent as grade IV.
Conclusion: Laryngeal involvement is common in pemphigus vulgaris and must be considered at the point of
diagnosis. Grade I lesions are the most frequent.
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Introduction
Pemphigus vulgaris is an autoimmune bullous disease
characterised by the development of intraepithelial blis-
ters on the skin and/or mucosa secondary to immuno-
globulin (Ig) G antibody synthesis against desmoglein,
a desmosomal glycoprotein present in keratinocytes.1
Two clinical subtypes of pemphigus vulgaris have
been defined. The mucosal form of pemphigus vulgaris
is characterised by a predominant anti-desmoglein 3
autoimmune response. In contrast, the mucocutaneous
form of pemphigus vulgaris shows a combined anti-
desmoglein 3 and anti-desmoglein 1 autoantibody
response.1
Laryngeal lesions due to pemphigus vulgaris are
rarely reported, and the majority of such reports
describe only the presence of such lesions, not their
endoscopic location.1–6
It is important to note that pemphigus vulgaris is
a very rare disease with an estimated incidence of
0.7 patients per 100 000. The mean age of patients
at the time of disease presentation is 40–50 years.
There is an increased incidence in Jewish individ-
uals, especially Ashkenazic Jews, and Mediterranean
populations.7,8
Generally, the mucosal lesions of pemphigus vul-
garis precede the skin lesions. It is not uncommon for
the initial diagnosis of the disease to be made by an oto-
laryngologist, based on a biopsy of oral mucosa.9
The term pemphigus refers to a complex of diseases
classified into six different types: (1) pemphigus folia-
ceus (erythematosus, classic and endemic, also named
‘fogo selvagem’ or wild fire); (2) pemphigus vulgaris;
(3) drug-induced pemphigus; (4) paraneoplastic pem-
phigus; (5) IgA pemphigus; and (6) herpetiform pem-
phigus (a clinical variant of either pemphigus
vulgaris or foliaceus).
Endemic pemphigus foliaceus shares the same clini-
cal, histological and immunological profile as the
classic form; however, it shows unique epidemiological
features, such as the presence of familial cases and
a high prevalence in South America, especially
Brazil.10 This type of pemphigus has no involvement
of the oral and upper airway mucosa, whereas pemphi-
gus vulgaris does involve such mucosa.11
The most comprehensive study to date of laryngeal
pemphigus vulgaris is a 2007 paper by España et al.
describing laryngeal involvement in 16 patients under-
going ENT endoscopic examination.1
However, there is currently no uniform classification
of laryngeal involvement in pemphigus vulgaris, par-
ticularly with regard to lesion characteristics and
locations within the supraglottis and glottis.
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Such classification is important as a guide for
disease treatment. The presence of lesions in the
larynx, for example, requires the use of more aggressive
therapy because of the risk of acute respiratory failure.
In addition, the absence of a classification system,
derived from proper endoscopic examination of a
reasonable number of cases, makes it difficult to
compare the various studies, and also to compare the
incidence of laryngeal lesions in pemphigus vulgaris
patients from different regions of the world.
Thus, the aims of our study were: (1) to investigate
laryngeal involvement in a large series of patients
with pemphigus vulgaris, using endoscopic ENT
examination; (2) to characterise lesions according to
their localisation within the larynx; and (3) to establish
a classification of laryngeal involvement in pemphigus
vulgaris based on the location of lesions.
To our knowledge, this is the first attempt to estab-
lish such a classification in a large series of cases.
Materials and methods
A prospective study was conducted at the ENT out-
patient unit of Hospital das Clinicas – São Paulo
University Medical School over six years. This study
was approved by the ethics commission at our insti-
tution (approval number 0465/08).
We included 40 sequentially treated patients with
pemphigus vulgaris diagnosed by clinical, histological
and immunofluorescence criteria, who were seen at
either the ENT department or the dermatology depart-
ment of the same institution. All patients had skin and/
or oral cavity lesions.
All patients underwent endoscopic ENT examina-
tion, using a Ferrari Medicals (São Paulo, Brazil)
halogen lamp light source (250 W) and either a flexi-
ble naso-pharyngo-laryngeal endoscope (Olympus
3.4 mm ENF type P4; Tokyo, Japan) or a rigid 70°
laryngeal telescope (Storz Hopkins, Tuttlingen,
Germany). Local anaesthesia was used, with topical
application of 2 per cent tetracaine to the nose or 10
per cent lidocaine to the oral cavity. Patients underwent
ENT endoscopic examination whether they com-
plained of laryngeal symptoms or not. None of the
patients in this study had received any kind of treatment
prior to ENT evaluation.
The patients did not undergo laryngeal biopsy;
rather, their diagnosis was confirmed from a biopsy
of oral mucosa, as their laryngeal lesions were similar
to their oral cavity lesions. Fragments of oral mucosa
were removed under local anaesthesia with 2 per cent
xylocaine, and sent for histological examination and
for direct immunofluorescence analysis.
A classification of laryngeal lesions was developed
based on their location. Lesions were classified as
grade I, II, III or IV, according to the number of sites
affected. Grade I lesions involved only the epiglottis.
Grade II lesions were situated on the supraglottis,
with or without lesions on the epiglottis. Grade III
lesions involved the piriform sinuses or ventricular
folds, with or without grade I or II type lesions.
Grade IV lesions involved the vocal folds, with or
without other regions of the larynx. This classification
system is summarised in Table I.
Results and analysis
In our study females predominated over males, with
respective proportions of 80 per cent (n= 32) and 20
per cent (n= 8). Patient age varied from 13 to 78
years, with a mean age of 46.35 years. Twenty-nine
(72.5 per cent) patients had the mucocutaneous form
of pemphigus vulgaris and 11 (27.5 per cent) had the
mucosal form.
The incidence of laryngeal symptoms is shown in
Table II. In total, 95 per cent of our patients had
active lesions due to pemphigus vulgaris.
Table III shows the grading of the laryngeal lesions
according to our suggested classification system.
Legions classified as grades I, II and III can be seen
in Figures 1, 2 and 3, respectively. Five of the seven
patients with vocal fold involvement had only corditis,
while the other two had intact blisters (Figure 4). It is
possible that some patients might have had subglottic
lesions; however, such lesions are difficult to locate
and we did not identify them in any of our patients.
Discussion
Most of the information on laryngeal manifestations
of pemphigus vulgaris has come from reports of
TABLE I
PROPOSED CLASSIFICATION OF LARYNGEAL LESIONS
Grade Location
I Epiglottis
II Supraglottis± grade I lesions
III Piriform sinuses & ventricular folds± grade I and/or
grade II lesions
IV Vocal folds± lesions of other grades
TABLE II
LARYNGEAL SYMPTOM INCIDENCE
Symptom Patients (n (%))
Dysphonia 10 (25)
Throat pain 19 (47.5)
Pain on swallowing 23 (57.5)
TABLE III
LARYNGEAL LESION GRADE INCIDENCE
Grade Patients (n (%))
I 15 (39.47)
II 8 (21.05)
III 8 (21.05)
IV 7 (18.42)
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individual cases.3–6 Only a few of the patients
described in these reports underwent ENT evaluation,
and reports of laryngeal lesions only describe their
presence or absence. Our study is the first large series
in which laryngeal lesions were reported according to
their localisation in the larynx, and in which all patients
with a diagnosis of pemphigus vulgaris underwent
ENT endoscopic examination.
Almost half of our patients had experienced pharyn-
geal or laryngeal symptoms; however, upon endo-
scopic evaluation the proportion of these patients
with active laryngeal lesions was approximately 95
per cent.
In España and colleagues’ Spanish study of 16 pem-
phigus vulgaris patients examined via ENT endoscopy,
active laryngeal lesions were found in 88 per cent (n=
14) of their patients.1 The majority of these authors’
patients (67 per cent) had the mucocutaneous form of
pemphigus vulgaris; similarly, 72.5 per cent of our
study patients had the mucocutaneous form.
In Hale and colleagues’ US study of 53 patients with
pemphigus vulgaris, only 7 were submitted to ENT
endoscopic examination; of these 7, active laryngeal
lesions were identified endoscopically in 57 per cent
(n= 4).2
In both the above studies, the authors only reported
whether their patients had active lesions or not; the
exact laryngeal location of lesions was not mentioned.
We found that grade I lesions (Figure 1) were the
most common type of laryngeal lesion in our patients
with pemphigus vulgaris. This high incidence of epi-
glottal lesions may be due to swallowed food causing
frequent mucosal trauma at this site. It is also relevant
that the histological structure of the supraglottic
mucosa is similar to that of the oral cavity mucosa.
This also explains why all of the grade II and III
lesions were ulcers (see Figure 3), and why the majority
(71.4 per cent) of patients with grade IV lesions had
intact blisters on the vocal folds (see Figure 4).
The erosive and bullous lesions located in the larynx
of patients with pemphigus vulgaris are sufficiently
characteristic to enable an experienced ENT specialist
to assess the damage caused by the disease.
FIG. 1
Rigid laryngeal telescopic view showing active pemphigus vulgaris
lesions on the epiglottis (grade I).
FIG. 2
Rigid laryngeal telescopic view showing active pemphigus vulgaris
lesions on the epiglottis and right aryepiglottic fold (grade II).
FIG. 3
Rigid laryngeal telescopic view showing active pemphigus vulgaris
lesions on the laryngeal face of the epiglottis, right aryepiglottic fold
and right ventricular fold (grade III).
FIG. 4
Flexible naso-pharyngo-laryngeal endoscopic view showing intact
blisters on both vocal folds (grade IV).
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Therefore, in our study biopsy of oral mucosa or skin
was considered sufficient to confirm the diagnosis of
the disease, avoiding the need for biopsy of laryngeal
lesions. In addition, all patients responded well to the
treatment given (usually high-dose corticosteroids),
confirming that their laryngeal lesions were due to
pemphigus vulgaris.
The classification proposed in this paper has a clear
objective: to grade the laryngeal involvement according
to the extent and severity of lesions. This is important
because it guides therapy: the higher the grade, the
higher the corticosteroid dose that should be
administered.
• Laryngeal involvement of pemphigus vulgaris
is common
• Knowledge of laryngeal involvement is
important to improve treatment
• A lesion classification system is proposed
based on laryngeal location
Our classification system is not perfect. It does not
include a grade for subglottic involvement; this is
because these lesions are difficult to identify using
endoscopic equipment. In order to describe such
lesions with more precision, we recommend a broncho-
scopic examination.
Conclusion
Laryngeal involvement of pemphigus vulgaris is
common and must be considered at the point of diagno-
sis. The supraglottic region is the most commonly
involved, although involvement of the vocal folds can
be present. Endoscopic examination is important in
patients both with and without laryngeal symptoms,
in order to enable examination of a greater area of
mucosa and to guide therapy.
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